<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <title>Prospective Grant of an Exclusive Patent License: Development and Commercialization of Natural Killer Cell Therapies for Cancer</title>
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <style>
        body { font-family: Arial, sans-serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { color: #333; }
        .metadata { color: #666; font-size: 0.9em; }
        .summary { margin-top: 20px; line-height: 1.5; }
        .source { margin-top: 20px; }
    </style>
</head>
<body>
    <h1>Prospective Grant of an Exclusive Patent License: Development and Commercialization of Natural Killer Cell Therapies for Cancer</h1>
    <div class="metadata">Published: 2026-02-05 11:15:48</div>
    <div class="summary">The National Cancer Institute, an institute of the National Institutes of Health, Department of Health and Human Services, is contemplating the grant of an Exclusive Patent License to practice the inventions embodied in the Patents and Patent Applications listed in the Supplementary Information section of this notice to Replay Holdings LLC ("Replay") located in San Diego, California.</div>
    <div class="source">Source: <a href="https://www.federalregister.gov/documents/2022/12/30/2022-28404/prospective-grant-of-an-exclusive-patent-license-development-and-commercialization-of-natural-killer" target="_blank" rel="noopener noreferrer">https://www.federalregister.gov/documents/2022/12/30/2022-28404/prospective-grant-of-an-exclusive-patent-license-development-and-commercialization-of-natural-killer</a></div>
</body>
</html>
